Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the ...

A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ...

The gas xenon, like the other noble, or inert, gases, is known for doing very little. The class of elements, because of its ...

Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that ...

A groundbreaking study reveals that Americans over 55 now face a 42% risk of developing dementia, significantly higher than ...

As the American population ages, a new study finds the average lifetime risk of dementia for adults over 55 is around 42 ...

Dartmouth Health is the only health care system on the East Coast to be part of the newly launched Brain Health Navigator ...

A new study found a link between a common type of herpes virus and Alzheimer's disease. Experts explain the finding—but there ...

Most treatments being pursued today to protect against Alzheimer’s disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research from Mass General Brigham and ...

More than six million Americans age 65 and up are living with Alzheimer’s including more than 35,000 Nebraska residents.

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...